KDOQI (Kidney Disease Outcomes Quality Initiative)
NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI | Pediatric Bone | Anemia 2006 |
Updates 2006

Clinical Practice Guidelines and Clinical Practice Recommendations
2006 Updates
Hemodialysis Adequacy
Peritoneal Dialysis Adequacy
Vascular Access


I.  CLINICAL PRACTICE GUIDELINES FOR HEMODIALYSIS ADEQUACY

WORK GROUP BIOGRAPHIES

John T. Daugirdas, MD (Co-Chair), is a Clinical Professor of Medicine at the University of Illinois College of Medicine. His areas of interest include dialysis adequacy and dialysis hypotension. He is a member of the American Society of Nephrology and the International Society of Nephrology and a founding member of the International Society of Hemodialysis. He was the Principal Investigator of one of the 15 Clinical Centers participating in the HEMO Study and currently is a Consultant to the Data Coordinating Center for the Frequent Hemodialysis Network trial of short-daily and nocturnal hemodialysis. Dr Daugirdas is one of the editors of the Handbook of Dialysis and is founding editor of the electronic journal, Hypertension, Dialysis, and Clinical Nephrology. He has received grants from Watson, American Regent, Aksys, Nephros, RRI, HDC Medical, Advanced Renal Technologies, Amgen, Ortho Biotech, Shire, Roche, Astra Zeneca, and Neurochem.

Thomas A. Depner, MD (Co-Chair), is a Professor of Medicine in the Department of Internal Medicine, Division of Nephrology, at the University of California, Davis School of Medicine. He trained at the University of Portland in Oregon, at Johns Hopkins University Medical School in Baltimore, and at Case Western Reserve University, where he completed his residency in internal medicine at University Hospitals in Cleveland. He is a practicing board-certified nephrologist with a long-standing interest in hemodialysis. He currently is the director of dialysis services at the University of California, Davis, and has authored a textbook on the prescription of hemodialysis. He is a member of the American Society of Nephrology, the International Society of Nephrology, the American Society for Artificial Internal Organs, and a founding member of the International Society of Hemodialysis. He was involved as a Principal Investigator during the HEMO Study and similarly is involved in the NIH-Clinical Trial: Frequent Hemodialysis Network clinical trial. He has been a member of the board of trustees for the American Society for Artificial Internal Organs since 1997 and is a past president of that organization. He has served on the dialysis advisory council for the American Society of Nephrology and on the editorial board of NephSAP.

Stuart Goldstein, MD, is an Associate Professor of Pediatrics at the Baylor College of Medicine in Houston, TX. He is Medical Director of the Dialysis Unit at the Texas Children's Hospital and Administrative Director of the Pheresis Service at the Texas Children's Hospital, both of Houston. He is a member of the American Academy of Pediatrics, the American Society of Nephrology, the International Pediatric Nephrology Association, the American Society of Pediatric Nephrology, the International Society of Nephrology, and the Society for Pediatric Research. In addition, he is on the Medical Review Board for the End-Stage Renal Disease Network of Texas, the Pediatric Nephrologist Representative for the International Society of Nephrology Commission of Acute Renal Failure, on the Clinical Affairs Committee for the American Society of Pediatric Nephrology, on the Dialysis Advisory Group for the American Society of Nephrology, and on the Training/Certification Committee of the American Society of Pediatric Nephrology. He has received grants from Gambro Renal Products, Dialysis Solutions Inc, Baxter Healthcare, B. Braun Inc, Amgen Inc, Abbott Laboratories, and Toray Inc. He has also lectured for Genentech. Dr Goldstein has received research funds, grants, or contracts from American Academy of Pediatrics, Baxter Healthcare, Dialysis Solutions, Inc., Gambro Renal Products, Genentech, Luitpold Pharmaceuticals, NxStage Inc., and The University of Missouri.

Todd S. Ing, MD, joined the Hines Veterans Affairs Hospital as a nephrologist and the Loyola University Chicago Stritch School of Medicine as a faculty member in 1976, after a number of years in private practice. Committed to medical education, he is an editor of the Handbook of Dialysis. Topics of special interest to him include the formulation of dialysates, bicarbonate-buffered peritoneal dialysis, first-use syndrome, peritoneal sclerosis, peritoneal fluid eosinophilia, dialysis ascites, and dialysis-associated pericarditis. Dr Ing has received research funds, grants, or contracts from Abbott Laboratories and Aksys Ltd.

Victoria Kumar, MD, is Associate Professor of Medicine, Department of Internal Medicine, Division of Nephrology, University of California Davis Medical Center. Dr Kumar's fellowship was at University of California Davis Medical Center. Dr Kumar also is staff physician at the Kaiser Permanente Medical Group.

Klemens B. Meyer, MD, is Associate Professor of Medicine at Tufts University School of Medicine. He serves as Director of Dialysis Services, Chair of the Health Information Committee, and Division of Nephrology Webmaster at Tufts-New England Medical Center. He founded Dialysis Clinic Inc's (DCI's) Outcomes Monitoring Program and serves as DCI's Medical Director for Information Technology. He has chaired both the Medical Review Board and the Board of Directors for End-Stage Renal Disease Network 1. He participated in the design and execution of the HEMO and CHOICE Studies. He is an active participant in the NKF KEEP programs and other regional chronic kidney disease screening and education programs. Dr Meyer's particular interests include informatics and decision support in chronic kidney disease stages IV and V and clinical applications of measures of patient experience. Dr Meyers has received research funds, grants, or contracts from Primary Insight Contributor Network, MEDA Corp/Leerink Swann & Co., and Gerson Lehram Healthcare Council.

Keith Norris, MD, is board certified in internal medicine and nephrology and is a certified hypertension specialist. He is the director of the Clinical Research Center at the Charles R. Drew University of Medicine and Science in Los Angeles, CA, where he also serves as the Vice-President of Research. He serves as a continuing quality improvement and quality assurance advisor to industry and has published more than 100 articles and book chapters. He is the principal investigator for a National Institutes of Health comprehensive center for health disparities in chronic kidney disease. Dr Norris has received research funds, grants, or contracts from Abbott Laboratories, Amgen, Genzyme/Bone Care International, Merck, and Pfizer.